Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.

Véronique Perrier; Jérôme Solassol; Carole Crozet; Yveline Frobert; Chantal Mourton-Gilles; Jacques Grassi; Sylvain Lehmann

doi:10.1111/j.1471-4159.2004.02356.x

Journal articles

Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.

Véronique Perrier ^{1, *} Jérôme Solassol ¹ Carole Crozet ¹ Yveline Frobert ² Chantal Mourton-Gilles ³ Jacques Grassi ² Sylvain Lehmann ¹

* Corresponding author

1 IGH - Institut de génétique humaine

2 SPI - Service de Pharmacologie et Immunoanalyse

3 Institut de Biotechnologie-Pharmacologie

Keywords : antibodies mechanism and therapeutic prion diseases anti-prion agent

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadatas

https://www.hal.inserm.fr/inserm-00143226
Contributor : Veronique Perrier <>
Submitted on : Wednesday, April 25, 2007 - 11:13:04 AM
Last modification on : Wednesday, July 8, 2020 - 3:37:12 AM
Long-term archiving on: : Wednesday, April 7, 2010 - 2:06:11 AM

Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.

Files

Identifiers

Collections

Citation

Export

Metrics

469

1746

Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.

Files

Identifiers

Collections

Citation

Export

Share

Metrics

469

1746